SCHEMBL26525941

SCHEMBL26525941

CCCC(CCC)c1nc2n(c1C)CCCC2

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.34
ALDH1A1 P00352 2/20 0.33
TP53 P04637 4/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.32
LMNA P02545 1/20 0.32
HSD11B1 P28845 2/20 0.32
HSD11B2 P80365 1/20 0.32
PI4KA P42356 1/20 0.31
PI4K2B Q8TCG2 1/20 0.31
PI4K2A Q9BTU6 1/20 0.31
PI4KB Q9UBF8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23890951 0.78 POLB (0.43) POLBATMSMN1; SMN2ALDH1A1TP53
SCHEMBL10239531 0.71 POLB (0.43) POLBATMSMN1; SMN2ALDH1A1TP53
SCHEMBL13360488 0.70 POLB (0.48) POLBATMSMN1; SMN2ALDH1A1NPC1
SCHEMBL10239182 0.69 POLB (0.52) POLBATMSMN1; SMN2ALDH1A1NPC1
SCHEMBL19006734 0.69 POLB (0.52) POLBATMSMN1; SMN2ALDH1A1NPC1
SCHEMBL19055354 0.67 KDM4E (0.43) POLBATMSMN1; SMN2
SCHEMBL22166766 0.67 POLB (0.39) POLBSMN1; SMN2ALDH1A1TP53HPGD
SCHEMBL26525826 0.66
SCHEMBL13328166 0.65 TP53 (0.39) POLBATMSMN1; SMN2ALDH1A1TP53
SCHEMBL14278538 0.64 ATM (0.46) POLBATMSMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024089170-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2024-05-02 WO disclosed
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 WO disclosed